CD 158B, HUMAN
- CAS No.
- Chemical Name:
- CD 158B, HUMAN
- Synonyms
- CD 158B, HUMAN;KIK-K7 (HUMAN);KIR2DL3 (HUMAN);KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL3;KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, LONG CYTOPLASMIC TAIL, 3, HUMAN
- CBNumber:
- CB3664571
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MFCD06412193
- MOL File:
- Mol file
CD 158B, HUMAN Chemical Properties, Uses, Production
Description
Recombinant KIR2DL3 produced in E.Coli is a single, non-glycosylated polypeptide chain containing amino acids 23-223 and having a molecular mass of 22.2kDa.
The KIR2DL3 is purified by proprietary chromatographic techniques.
Source
Escherichia Coli
Background
Killer-cell immunoglobulin-like receptors (KIRs), are a family of cell surface glycoproteins found on Natural Killer (NK) Cells, which are important cells of the immune system. They control the killing function of these cells by interacting with MHC class I molecules, which are expressed on all cell types. This interaction allows them to identify virally infected cells or tumor cells that have a distinctive low level of Class I MHC on their surface. The majority of KIRs are inhibitory, which means that their recognition of MHC suppresses the cytotoxic activity of their NK cell. Only a limited number of KIRs have the capacity to activate cells.
The KIR genes are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). KIR molecules are extremely polymorphic, meaning their gene sequences differ significantly between individuals, so that different individuals have different arrays/repertoires of KIR genes.
The KIR proteins are categorized by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM). Whereas KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals.
KIR2DL3 is an inhibitory Killer Cell Ig-like Receptor (KIR, previously called p58 KIR, cl-6, NKAT2 or KIR-K7), which recognizes class I MHC molecules (HLA-Cw1, -Cw3, -Cw7, and Cw8). KIR2DL3 inhibits the activity of NK cells thus preventing cell lysis.
CD 158B, HUMAN Preparation Products And Raw materials
Raw materials
Preparation Products
CD 158B, HUMAN Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Adooq Bioscience LLC | -- | sales@adooq.cn | China | 6208 | 58 |
| ProSpec Tany TechnoGene Ltd | -- | info@prospecbio.com | China | 6874 | 58 |
| Alexis Corporation | -- | alexis-ch@alexis-corp.ch | Switzerland | 3596 | 74 |
| EMD Biosciences, Inc. | -- | technical@calbiochem.com | United States | 6527 | 66 |
| Supplier | Advantage |
|---|---|
| Adooq Bioscience LLC | 58 |
| ProSpec Tany TechnoGene Ltd | 58 |
| Alexis Corporation | 74 |
| EMD Biosciences, Inc. | 66 |
